News

Trinix Pharma Private Limited

Trinix Pharma Private Limited formally known as Towa Pharma Pvt. Ltd. stands as a pioneer
in advanced drug delivery—blending science with the art of formulation. Specializing in
complex dosage forms for rare and orphan diseases, Trinix offers end-to-end solutions from
pre-formulation to commercial manufacturing.
With a state-of-the-art WHO-GMP and EU-cGMP certified facility near Ahmedabad, it delivers
excellence in tablets and capsules with a capacity of 3 billion units annually. Embracing
CRAMS, bio-equivalence studies, and clinical trials, Trinix meets the highest global quality,
safety, and environmental standards.
Driven by innovation, precision, and sustainability, Trinix is committed to transforming
healthcare and creating value for clients, communities, and the pharmaceutical industry
worldwide.
Quality Mark Awards 2025 for Pharmaceutical Formulation & Manufacturing category goes
to Trinix Pharma Private Limited.

Wem India

Recent Posts

Mumbai-Based Encube Ethicals files DRHP with SEBI for Rs 3,000 Crore IPO

Mumbai-based Encube Ethicals Limited has filed its Draft Red Herring Prospectus (DRHP) with capital markets…

6 days ago

GIC subsidiary’s Gamnat Pte Ltd and Promoter Sunu Mathew lead Rs 371.3 crore investment in Leap India in Pre-IPO round

 Leap India (formerly known as Leap India Private Limited), the largest on-demand asset pooling provider…

1 week ago

Magnum SIF offered by SBI Mutual Fund launches its 2nd investment strategy ‘Magnum Equity Ex-Top 100 Long Short Fund’

SBI Mutual Fund, India’s largest fund house announces the launch of its 2nd investment strategy under…

1 week ago

Rooftop solar installations have exceeded 16,000 a day: Pralhad Joshi

“PM Surya Ghar Muft Bijli Yojana is transforming India's energy landscape by taking clean energy…

1 week ago

Property share files for Rs 4,846.80 million IPO of its 4th scheme

Property Share Investment Trust, India’s first registered Small and Medium Real Estate Investment Trust, has…

1 week ago

RBI Holds Rates as Growth and Inflation Outlook Improves Sanjay Chaturvedi, Chief Treasury Officer, Namdev Finvest Limited

Compared with its June policy, the RBI today kept the repo rate unchanged at 5.25%…

2 weeks ago